Advertisement
Canada markets closed
  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CAD/USD

    0.7317
    +0.0006 (+0.08%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • Bitcoin CAD

    83,380.46
    -2,657.04 (-3.09%)
     
  • CMC Crypto 200

    1,260.80
    -97.21 (-7.16%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     
  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     
  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     
  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     

Company News For Jun 20, 2018

Ross Stores (ROST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • AT&T Inc.’s T shares increased 0.6% after the company announced that there will be fewer commercials, personalized programming and smaller channel bundles following its acquisition of Time Warner

  • Shares of Foundation Medicine, Inc. FMI surged 28.5% on news that Swiss drug behemoth Roche was buying out the company for $2.4 billion

  • Cotiviti Holdings, Inc.’s COTV shares increased 10.3% after Verscend Technologies Inc agreed to buy the company for $4.9 billion

  • Shares of Sarepta Therapeutics, Inc. SRPT rose 36.8% after the company announced positive results from Phase 1/2 test on its microdystrophin gene therapy for Duchenne muscular dystrophy, or DMD


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Foundation Medicine, Inc. (FMI) : Free Stock Analysis Report
 
AT&T Inc. (T) : Free Stock Analysis Report
 
Sarepta Therapeutics, Inc. (SRPT) : Free Stock Analysis Report
 
Cotiviti Holdings, Inc. (COTV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research